11 - 20 out of 60Page size: 10
  1. 2022

  2. High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma

    Aydin, M., Tang, M. W., Wondergem, M. J., de Leeuw, D. C., Wegman, J. J., Biemond, B. J., van de Donk, N. W. C. J., Zweegman, S., Meijer, E. & Nur, E., Mar 2022, In: British journal of haematology. 196, 6, p. e67-e70

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  3. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease

    SCORE consortium, Gerritsma, J., Bongaerts, V., Eckhardt, C., Heijboer, H., Nur, E., Biemond, B., van der Schoot, E. & Fijnvandraat, K., Feb 2022, In: British journal of haematology. 196, 3, p. 769-776 8 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

    de Latour, R. G. P., Kulasekararaj, A., Iacobelli, S-M., Terwel, S. R., Cook, R., Griffin, M., Halkes, C. J. M., Recher, C., Barraco, F., Forcade, E., Vallejo, J-C., Drexler, B., Mear, J-B., Smith, A. E., Angelucci, E., Raymakers, R. A. P., de Groot, M. R., Daguindau, E., Nur, E., Barcellini, W., & 30 othersRussell, N. H., Terriou, L., Iori, A-P., la Rocca, U., Sureda, A., Sánchez-Ortega, I., Xicoy, B., Jarque, I., Cavenagh, J., de Fontbrune, F. S., Marotta, S., Munir, T., Tjon, J. M. L., Tavitian, S., Praire, A., Clement, L., Rabian, F., Marano, L., Hill, A., Palmisani, E., Muus, P., Cacace, F., Frieri, C., van Lint, M-T., Passweg, J. R., Marsh, J. C. W., Socié, G. R., Mufti, G. J., Dufour, C. & Risitano, A. M., 6 Jan 2022, In: New England journal of medicine. 386, 1, p. 11-23 13 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. 2021

  6. Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis

    Aydin, M., Dovern, E., Leeflang, M. M. G., de la Fuente, J., Kassim, A. A., Biemond, B. J. & Nur, E., Dec 2021, In: Transplantation and Cellular Therapy. 27, 12, p. 1004.e1-1004.e8

    Research output: Contribution to journal › Review article › Academic › peer-review

  7. Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors

    Gaartman, A. E., Sayedi, A. K., Gerritsma, J. J., de Back, T. R., van Tuijn, C. F., Tang, M. W., Heijboer, H., de Heer, K., Biemond, B. J. & Nur, E., 1 Sep 2021, In: British journal of haematology. 194, 5, p. 899-907 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Back to base pairs: What is the genetic risk for red bloodcell alloimmunization?

    Gerritsma, J. J., Oomen, I., Meinderts, S., van der Schoot, C. E., Biemond, B. J., van der Bom, J. G., SCORE consortium, Fijnvandraat, K., van Beers, E. J., Beijlevelt, M., Brons, P. P. T., Cnossen, M. H., Dovern, L., Heijboer, H., Hofstede, F., Kerkhoffs, J. L. H., Nur, E., Ootjers, C., de Pagter, P. J., Rijneveld, A. W., & 7 othersSchols, S. E. M., Smiers, F. J., Suiker, M. H., Teuben, S. A. M. C., van Tuijn, C. F. J., van Vliet, I. & Zwagemaker, E., Jul 2021, In: Blood reviews. 48, 100794.

    Research output: Contribution to journal › Review article › Academic › peer-review

  9. Biomarkers to predict infection and infection-related complications during chemotherapy-induced neutropenia in acute myeloid leukaemia: a pilot study

    van de Geer, A., Zandstra, J., Tanck, M. W. T., Nur, E., van Mierlo, G., Jongerius, I., van Bruggen, R., Zeerleder, S. S. & Kuijpers, T. W., Jun 2021, In: British journal of haematology. 193, 5, p. 1008-1012 5 p.

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  10. Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

    Biemond, B. J., Tombak, A., Kilinc, Y., Al-Khabori, M., Abboud, M., Nafea, M., Inati, A., Wali, Y., Kristensen, J., Kowalski, J., Donnelly, E., Ohd, J., TVOC01 Investigators Group, Nur, E., Rijneveld, A. W., Antmen, A., Reid, M., Ukala, G., Kirven-Dawes, L., Yeates, C., & 2 othersWong, H. & Al Sultan, A., 1 May 2021, In: Lancet. Haematology. 8, 5, p. e334-e343

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Impairment of Cerebrovascular Hemodynamics in Patients With Severe and Milder Forms of Sickle Cell Disease

    Afzali-Hashemi, L., Baas, K. P. A., Schrantee, A., Coolen, B. F., van Osch, M. J. P., Spann, S. M., Nur, E., Wood, J. C., Biemond, B. J. & Nederveen, A. J., 20 Apr 2021, In: Frontiers in physiology. 12, 645205.

    Research output: Contribution to journal › Article › Academic › peer-review

  12. Impact of sickle cell disease on patientsʼ daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY)

    Osunkwo, I., Andemariam, B., Minniti, C. P., Inusa, B. P. D., el Rassi, F., Francis-Gibson, B., Nero, A., Trimnell, C., Abboud, M. R., Arlet, J-B., Colombatti, R., de Montalembert, M., Jain, S., Jastaniah, W., Nur, E., Pita, M., DeBonnett, L., Ramscar, N., Bailey, T., Rajkovic-Hooley, O., & 1 othersJames, J., 1 Apr 2021, In: American journal of hematology. 96, 4, p. 404-417 14 p.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 3 4 5 6 Next

ID: 76121